1. Home
  2. IPSC vs BRFH Comparison

IPSC vs BRFH Comparison

Compare IPSC & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • BRFH
  • Stock Information
  • Founded
  • IPSC 2019
  • BRFH 2005
  • Country
  • IPSC United States
  • BRFH United States
  • Employees
  • IPSC N/A
  • BRFH N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • BRFH Packaged Foods
  • Sector
  • IPSC Health Care
  • BRFH Consumer Staples
  • Exchange
  • IPSC Nasdaq
  • BRFH Nasdaq
  • Market Cap
  • IPSC 49.6M
  • BRFH 47.3M
  • IPO Year
  • IPSC 2021
  • BRFH N/A
  • Fundamental
  • Price
  • IPSC $0.60
  • BRFH $3.33
  • Analyst Decision
  • IPSC Strong Buy
  • BRFH Strong Buy
  • Analyst Count
  • IPSC 5
  • BRFH 1
  • Target Price
  • IPSC $3.33
  • BRFH $4.50
  • AVG Volume (30 Days)
  • IPSC 1.0M
  • BRFH 5.5K
  • Earning Date
  • IPSC 08-07-2025
  • BRFH 08-13-2025
  • Dividend Yield
  • IPSC N/A
  • BRFH N/A
  • EPS Growth
  • IPSC N/A
  • BRFH N/A
  • EPS
  • IPSC N/A
  • BRFH N/A
  • Revenue
  • IPSC $114,898,000.00
  • BRFH $10,818,000.00
  • Revenue This Year
  • IPSC $1,064.82
  • BRFH $42.31
  • Revenue Next Year
  • IPSC N/A
  • BRFH $40.92
  • P/E Ratio
  • IPSC N/A
  • BRFH N/A
  • Revenue Growth
  • IPSC 8286.72
  • BRFH 22.03
  • 52 Week Low
  • IPSC $0.34
  • BRFH $1.81
  • 52 Week High
  • IPSC $3.29
  • BRFH $4.60
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 55.47
  • BRFH 57.01
  • Support Level
  • IPSC $0.52
  • BRFH $3.18
  • Resistance Level
  • IPSC $0.57
  • BRFH $3.49
  • Average True Range (ATR)
  • IPSC 0.04
  • BRFH 0.30
  • MACD
  • IPSC 0.00
  • BRFH 0.03
  • Stochastic Oscillator
  • IPSC 66.10
  • BRFH 68.35

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks: